July 23, 2014 Ultragenyx Appoints Sunil Agarwal, M.D. as Chief Medical Officer and Senior Vice President
July 23, 2014 Cross-border merger of BioAlliance Pharma and Topotarget legally effective as of July 22, 2014
July 14, 2014 HealthCap VI company Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
July 02, 2014 New clinical review gives practicing physicians’ recommendations for how to use Arocrine’s FeNO-Test in routine clinical practice.